Alibaba Health Information Technology Limited
0241Pharmaceuticals
HK$2.76−1.25%As of Oct 29vs prior close
- Market cap
- $5.7B
- P/E (TTM)
- 19.5×
- P/E (FY1)
- 17.4×
- From 52W high
- −62.25%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥34.3B
- Net margin
- 5.65%
- Dividend yield
- –
Nomior Score
34
Steady ProfileBottom 19% of the scored universe
Growth57
Quality42
Value46
Momentum8
Resilience54
Growth
+8.58%revenue a year over 3 fiscal years
YE23 CN¥26.8BLTM CN¥34.3B
Connections
Revenue to profitYE26
6% of revenue became net profit, up 1 pt on a year.